News
March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial evaluating the safety and efficacy of Ocelot. The device is the first chronic total occlusion (CTO) crossing catheter using forward-looking optical coherence tomography (OCT) top treat patients with peripheral artery disease (PAD).
March 09, 2012
This video, provided by Boston Scientific, shows how to implant the subcutaneous implantable cardioverter defibrillator ...
March 09, 2012Technology
March 9, 2012 — At the 2012 Tape Summit, Fujifilm Medical Systems U.S.A. Inc. and Fujifilm Recording Media U.S.A. Inc. announced a joint venture to launch the Permivault cloud-based storage service that expands upon Fujifilm Medical Systems’ Synapse managed services platform.
March 09, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
March 9, 2012 — Researchers have developed a method to label transplanted cells so they can be tracked by magnetic resonance imaging (MRI). In the future, as cell therapies become a more integral part of regenerative medicine and tumor treatment, there could be increased need to measure how many transplanted immune or stem cells reach their target.
March 09, 2012News
March 8, 2012 — Transgenomic Inc. announced the publication of a new study by researchers at Vanderbilt University that further validates the role of both genes found in the company’s PGxPredict: Clopidogrel (Plavix) Panel, a comprehensive test to predict a patient’s response to clopidogrel (Plavix).
March 08, 2012News
March 8, 2012 — Researchers at Sentara Cardiovascular Research Institute are among the top enrollers out of 69 leading heart centers in the United States involved in a clinical trial designed to use a new investigational device to evaluate the safety and efficacy of a physician-directed patient self-management system.
March 08, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
March 8, 2012 — Edwards Lifesciences Corp. reported March 3 it filed its official response to the Centers for Medicare and Medicaid Services (CMS) on its proposed national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR).
March 08, 2012
News
March 7, 2012 — Critical Diagnostics announced results from a multi-center study in ambulatory heart failure patients which confirmed that a contemporary panel of biomarkers, including ST2, was strongly predictive of risk and significantly improved the likelihood of identifying patients at risk for adverse events compared to the Seattle Heart Failure Model (SHFM).
March 07, 2012
News
March 7, 2012 — The U.S. Patent and Trademark Office (USPTO) granted biopharmaceutical development company BioLineRx for ...
March 07, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
March 7, 2012 — The U.S. Food and Drug Administration (FDA) cleared the Abbott Absolute Pro vascular self-expanding stent system for use in iliac artery peripheral artery disease (PAD) lesions.
March 07, 2012
News
March 7, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of updates to the prescribing information concerning interactions between protease inhibitors and certain statin drugs. Protease inhibitors and statins taken together may raise the blood levels of statins and increase the risk for muscle injury, or myopathy.
March 07, 2012
Technology
March 7, 2012 — Covidien announced the global launch of the Optivantage dual-head computed tomography (CT) contrast media delivery system with simultaneous injection.
March 07, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
March 7, 2012 — Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial recommendations for creating and maintaining transcatheter aortic valve replacement (TAVR) programs. The recommendations are aimed at ensuring optimal care for patients with aortic stenosis, a form of valvular heart disease, as use of the new TAVR procedure grows.
March 07, 2012
News
March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) to Japanese patients for the first time, Cook Medical has received PMDA approval to sell the Zilver PTX Drug-Eluting Peripheral Stent in Japan. The device, indicated for treating PAD in the superficial femoral artery (SFA), is the first stent available in Japan approved for use in the SFA. Its approval also makes Zilver PTX the only drug-eluting peripheral stent available in that country.
March 06, 2012
News
March 6, 2012 — Vascular Magnetics announced it has raised $7 million to advance development of a drug delivery system using magnetically targeted nanoparticles to treat peripheral artery disease (PAD). Based in West Philadelphia, the company announced that Devon Park Bioventures, of Wayne, Pa., is the sole investor in the Series A financing agreement.
March 06, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now